Leukemia cells from the above AML subtypes were found generally sensitive to DOT1Li, and DOT1Li treatments repressed “stemness” gene-expression programs, supporting a broader role of DOT1L and “stemness” TF nodes in AML biology (Figure 1D). This evidence concerns the gene DOT1L and acute myeloid leukemia.